Edition:
United Kingdom

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

3.05USD
8:59pm GMT
Change (% chg)

$-0.17 (-5.28%)
Prev Close
$3.22
Open
$3.22
Day's High
$3.22
Day's Low
$3.04
Volume
104,207
Avg. Vol
272,915
52-wk High
$10.54
52-wk Low
$2.37

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.275
Jun '18 0.00 -0.235
Mar '18 0.00 -0.149
FY 2017 Dec '17 0.00 -0.201
Sep '17 0.00 -0.145
Jun '17 0.00 -0.207
Mar '17 0.00 -0.264
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 5 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 5 -0.26 -0.19 -0.34 -0.36
Quarter Ending Jun-19 5 -0.27 -0.22 -0.35 -0.36
Year Ending Dec-19 6 -1.10 -0.80 -1.37 -1.40
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.49 33.71
P/E High - Last 5 Yrs. -- 45.03 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) -- 4.12 6.28
Price to Book (MRQ) 9.56 5.11 5.27
Price to Tangible Book (MRQ) 13.54 5.85 6.78
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 56.84 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.31 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 4.15 5.88
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 54.86 45.05 47.26
EPS (TTM) vs TTM 1 Yr. Ago 31.51 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 3.69 2.98 3.08
LT Debt to Equity (MRQ) 0.00 8.86 11.39
Total Debt to Equity (MRQ) 21.47 12.91 16.13
Interest Coverage (TTM) -70.74 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.65 53.79
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.95 12.87
Operating Margin (TTM) -- 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.31
Pre-Tax Margin (TTM) -- 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.61
Net Profit Margin (TTM) -- 11.08 3.31
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 959,737,456 844,195,039
Net Income/Employee (TTM) -1,604,929 113,812,018 100,058,867
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -65.83 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -85.78 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -92.43 16.30 15.99
Return on Equity - 5 Yr. Avg. -- 17.76 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 11.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Marinus Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 122.60 114.92 99 22
13 Week 410.66 385.79 99 39
26 Week 340.95 307.43 99 33
52 Week 342.36 274.93 99 9
YTD 587.62 503.87 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.42%
# of Holders: 125
Total Shares Held: 29,106,933
3 Mo. Net Change: -1,872,226
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 9
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.